DFDA

Venlafaxine (SNRI)

Treatment for Anxiety Disorder

Typical Dosage: 75-225mg daily

Effectiveness
75%
Safety Score
60%
Clinical Trials
4
Participants
30K

Comparative Safety Scale(Higher is safer)

Cyanide☠️
Meth💀
Cigarettes🚬
Chemo☢️
Alcohol🍺
Morphine💊
Antibiotics💉
Tylenol💊
Exercise🏃
Water💧
60
DangerousModerateSafe
Treatment Details
Dosage Range
75-225mg daily
Time to Effect
2-4 weeks
Treatment Duration
6-12 months, often longer
Evidence Quality
HIGH
Number Needed to Treat (NNT)
6(Treat 6 patients to see 1 additional successful outcome)
Number Needed to Harm (NNH)
9(Treat 9 patients to see 1 additional serious adverse event)
Confidence Score
88%confidence in effectiveness data
Health Economics
Annual Cost of Care
Drug Cost:$400
Monitoring:$200
Side Effect Mgmt:$120
Total Annual:$720
Cost-Effectiveness Analysis
Cost-Effectiveness Rating
GOOD
ICER
$55,000/QALY
QALYs Gained
0.23
Outcome-Based Costs
Cost per Responder
$1,309
Cost per Remission
$2,400
Comparison vs No Treatment
Cost Difference
+$720/year
More expensive
QALY Difference
+0.23 QALYs
Better outcomes
Dominance
No dominance
Venlafaxine (SNRI) Outcomes

for Anxiety Disorder

Efficacy Outcomes
Overall Effectiveness
+75%
Response Rate
+55%
Remission Rate
+30%
Common Side Effects
Nausea
+25%
Dizziness
+15%
Sweating
+18%
Sexual dysfunction
+25%

Sources:

wikipedia.org
tandfonline.com
tandfonline.com

WARNING: LIMITED TRIALS AVAILABLE

You can search for trials, but you probably can't join any because the 1% Treaty hasn't passed yet. Most trials are severely limited by lack of funding and bureaucratic barriers. Help change this!

Active Clinical Trials
No active trials currently recruiting for this treatment

No active trials found in ClinicalTrials.gov

Completed Clinical Trials
3 completed trials for Venlafaxine (SNRI) in Anxiety Disorder

Effectiveness of Long-Term Versus Short-Term Treatment of Generalized Anxiety Disorder With Venlafaxine XR

NCT00183274COMPLETEDPHASE4
View Study
268 participants
INTERVENTIONAL
Philadelphia, United States
Started: Jan 1, 2004

Efficacy of Online CBT for GAD Compared to Pharmaceutical Interventions

NCT04478526COMPLETEDNA
View Study
115 participants
INTERVENTIONAL
Kingston, Canada
Started: Apr 29, 2020

Anxiety and Depression in Epilepsy: A Treatment Study

NCT03464383COMPLETEDPHASE4
View Study
69 participants
INTERVENTIONAL
Winston-Salem, United States
Started: May 7, 2018